Product
Dorzolamide/Timolol Ophthalmic Solution
1 clinical trial
3 indications
Indication
GlaucomaIndication
Open-AngleIndication
ocular hypertensionClinical trial
Phase IV, Multicenter, Double-blind, Randomized, Controlled, Parallel-group, Trial to Evaluate the Efficacy and Safety of Dozolamide 2%/Timolol 0,5% PF vs Dorzolamide 2%/Timolol 0,5% BAK-preserved in OAG or OHStatus: Recruiting, Estimated PCD: 2024-10-04